Feedback / Questions
lirentelimab subcutaneous (AK002 SC) - Allakos
http://clinicaltrials.gov/ct2/show/NCT05155085
Jul 12, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next